Vital Innovations Holdings Ltd.(HK:6133)
HK$0.270.00 (0.00%)
HK:6133
Vital Innovations Holdings Ltd. financials statements
HK$0.27
At close:0.00 (0.00%)
Want to see HK:6133 full AI Analyst Report?
Vital Innovations Holdings Ltd. (6133) Ratios
0 Followers
Vital Innovations Holdings Ltd. Ratios
HK:6133's free cash flow for Q4 2025 was ¥5.38M. For the 2025 fiscal year, HK:6133's free cash flow was increased by ¥0.00 and operating cash flow was ¥5.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.07 | 4.68 | 5.00 | 6.46 | 6.57 |
| Quick Ratio | 5.07 | 4.65 | 4.99 | 6.38 | 6.38 |
| Cash Ratio | 0.02 | 0.06 | 0.19 | 0.39 | 0.27 |
| Solvency Ratio | -0.14 | -0.15 | -0.16 | -0.17 | -0.20 |
| Operating Cash Flow Ratio | 0.09 | -0.08 | -0.32 | 0.16 | -0.20 |
| Short-Term Operating Cash Flow Coverage | 0.80 | -0.40 | -1.21 | 2.16 | -1.61 |
| Net Current Asset Value | ¥ 463.34M | ¥ 479.46M | ¥ 502.68M | ¥ 522.30M | ¥ 538.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.05 | 0.05 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.03 | 0.06 | 0.07 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | 0.03 | 0.06 | 0.06 | 0.02 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.25 | 1.27 | 1.25 | 1.18 | 1.18 |
| Debt Service Coverage Ratio | -1.10 | -0.61 | -0.52 | -1.92 | -1.54 |
| Interest Coverage Ratio | -13.16 | -9.24 | -13.05 | -21.28 | -41.65 |
| Debt to Market Cap | 0.10 | 0.23 | 0.16 | 0.04 | 0.06 |
| Interest Debt Per Share | 0.02 | 0.04 | 0.04 | 0.01 | 0.02 |
| Net Debt to EBITDA | -0.73 | -1.24 | -0.53 | 1.85 | 0.59 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.53% | 0.56% | 0.36% | 0.43% | -0.07% |
| EBIT Margin | -2.54% | -1.81% | -2.32% | -1.53% | -2.98% |
| EBITDA Margin | -2.34% | -1.69% | -2.17% | -1.41% | -2.83% |
| Operating Profit Margin | -2.54% | -1.50% | -2.33% | -1.62% | -3.29% |
| Pretax Profit Margin | -2.64% | -1.98% | -2.49% | -1.61% | -3.06% |
| Net Profit Margin | -2.64% | -1.97% | -2.49% | -1.60% | -3.05% |
| Continuous Operations Profit Margin | -2.64% | -1.98% | -2.49% | -1.61% | -3.06% |
| Net Income Per EBT | 100.00% | 99.98% | 99.97% | 99.46% | 99.70% |
| EBT Per EBIT | 104.13% | 131.92% | 107.16% | 99.51% | 93.00% |
| Return on Assets (ROA) | -3.05% | -3.42% | -3.31% | -2.81% | -3.20% |
| Return on Equity (ROE) | -3.81% | -4.35% | -4.14% | -3.33% | -3.79% |
| Return on Capital Employed (ROCE) | -3.65% | -3.29% | -3.87% | -3.36% | -4.07% |
| Return on Invested Capital (ROIC) | -3.55% | -3.10% | -3.62% | -3.29% | -3.97% |
| Return on Tangible Assets | -3.05% | -3.42% | -3.31% | -2.81% | -3.20% |
| Earnings Yield | -13.24% | -17.08% | -10.02% | -9.86% | -10.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.18 | 7.05 | 950.63 | 1116.77 | 81.92 |
| Payables Turnover | 30.04 | 41.31 | 97.23 | 127.18 | 62.92 |
| Inventory Turnover | 0.00 | 272.10 | 687.53 | 135.70 | 37.81 |
| Fixed Asset Turnover | 450.83 | 372.19 | 1476.33 | 608.81 | 218.39 |
| Asset Turnover | 1.15 | 1.73 | 1.33 | 1.76 | 1.05 |
| Working Capital Turnover Ratio | 1.42 | 2.16 | 1.63 | 2.05 | 1.22 |
| Cash Conversion Cycle | 23.69 | 44.26 | -2.84 | 0.15 | 8.31 |
| Days of Sales Outstanding | 35.84 | 51.76 | 0.38 | 0.33 | 4.46 |
| Days of Inventory Outstanding | 0.00 | 1.34 | 0.53 | 2.69 | 9.65 |
| Days of Payables Outstanding | 12.15 | 8.84 | 3.75 | 2.87 | 5.80 |
| Operating Cycle | 35.84 | 53.10 | 0.91 | 3.02 | 14.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | -0.01 | -0.05 | 0.02 | -0.02 |
| Free Cash Flow Per Share | 0.01 | -0.01 | -0.05 | 0.02 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -4049.30 | 2208.86 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -4049.30 | 2208.86 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.76 | -0.36 | -1.19 | 1.72 | -1.28 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.01 | -0.05 | 0.01 | -0.03 |
| Free Cash Flow Yield | 7.73% | -8.99% | -19.48% | 8.73% | -9.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.56 | -5.85 | -9.98 | -10.14 | -9.79 |
| Price-to-Sales (P/S) Ratio | 0.20 | 0.12 | 0.25 | 0.16 | 0.30 |
| Price-to-Book (P/B) Ratio | 0.29 | 0.25 | 0.41 | 0.34 | 0.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.94 | -11.13 | -5.13 | 11.46 | -10.18 |
| Price-to-Operating Cash Flow Ratio | 12.94 | -11.13 | -5.14 | 11.46 | -10.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.48 | -7.17 | -0.51 | 0.68 | 0.13 |
| Enterprise Value Multiple | -9.28 | -8.07 | -12.01 | -9.62 | -9.94 |
| Enterprise Value | 145.00M | 145.37M | 217.60M | 148.55M | 189.47M |
| EV to EBITDA | -9.28 | -8.07 | -12.01 | -9.62 | -9.94 |
| EV to Sales | 0.22 | 0.14 | 0.26 | 0.14 | 0.28 |
| EV to Free Cash Flow | 14.04 | -13.16 | -5.37 | 9.61 | -9.61 |
| EV to Operating Cash Flow | 14.04 | -13.16 | -5.37 | 9.61 | -9.61 |
| Tangible Book Value Per Share | 0.55 | 0.57 | 0.59 | 0.62 | 0.64 |
| Shareholders’ Equity Per Share | 0.55 | 0.57 | 0.59 | 0.62 | 0.64 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.03 |
| Revenue Per Share | 0.79 | 1.25 | 0.98 | 1.28 | 0.79 |
| Net Income Per Share | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.04 | 1.09 | 1.08 | 1.05 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.60 | 0.53 | 1.94 | -0.88 | 0.96 |
Currency in CNY

